Internal Medicine, Endocrinology, Diabetes, & Metabolism · Torrance, CA
NPI
1538351812
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1124 W Carson St # Rb-1
Torrance, CA, 90502
Phone (310) 222-1866
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,205
22 services
Medicare patients, 2024
20
Average age 62
Drug cost, 2024
$588K
2,583 prescriptions
Company payments, 2023
$29.46
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Aram Mouzeyan prescribed most often to Medicare patients was Levothyroxine Sodium, with 434 prescriptions and refills. In total Aram Mouzeyan wrote 2,583 Medicare prescriptions that cost $588K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-30.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Levothyroxine Sodium Generic | 434 | 1,364 | 141 | $8,509 |
| Humulin N Insulin Nph Human Isophane | 204 | 598 | 82 | $55K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 160 | 423 | 72 | $4,588 |
| Insulin Glargine-Yfgn Generic | 159 | 440 | 67 | $23K |
| Humulin N Kwikpen Insulin Nph Human Isophane | 148 | 376 | 54 | $38K |
| Humulin R Insulin Regular, Human | 142 | 368 | 53 | $22K |
| Ozempic Semaglutide | 111 | 129 | 28 | $86K |
| Methimazole Generic | 106 | 345 | 41 | $2,234 |
| Humalog Kwikpen U-100 Insulin Lispro | 101 | 254 | 41 | $37K |
| Glipizide Generic | 92 | 268 | 38 | $1,371 |
| Metformin Hcl Generic | 66 | 203 | 24 | $717 |
| Hydrocortisone Generic | 64 | 209 | 26 | $3,864 |
| Humalog Insulin Lispro | 62 | 154 | 26 | $15K |
| Veo Insulin Syringe Syringe And Needle,insulin,1ml | 55 | 158 | 21 | $1,355 |
| Humulin R U-500 Kwikpen Insulin Regular, Human | 52 | 103 | 15 | $111K |
Brand drugs: 1,191 claims; generic drugs: 1,026 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Aram Mouzeyan $29.46 ($29.46 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbott Laboratories with $29.46.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 1 | $29.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.